Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?

Objective:In this study, we aimed to review the heart and left coronary artery doses over the years in patients who received breast cancer radiotherapy (RT).Materials and Methods:A total of 436 breast cancer patients of 2 RT centers treated between the years 2010 and 2018 were included. The mean hea...

Full description

Bibliographic Details
Main Authors: Pelin Altınok, Latif Korkmaz, Ayse Altınok, Nuran Beşe
Format: Article
Language:English
Published: Galenos Publishing House 2021-04-01
Series:European Journal of Breast Health
Subjects:
Online Access: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/were-we-able-to-reduce-cardiac-doses-in-breast-can/47124
_version_ 1828024986062815232
author Pelin Altınok
Latif Korkmaz
Ayse Altınok
Nuran Beşe
author_facet Pelin Altınok
Latif Korkmaz
Ayse Altınok
Nuran Beşe
author_sort Pelin Altınok
collection DOAJ
description Objective:In this study, we aimed to review the heart and left coronary artery doses over the years in patients who received breast cancer radiotherapy (RT).Materials and Methods:A total of 436 breast cancer patients of 2 RT centers treated between the years 2010 and 2018 were included. The mean heart doses (HeartDmean-HDM) and left coronary artery mean doses (LDM) were analyzed using nonparametric tests. The conventional RT (CRT) was 50 Gy/2 Gy in 5 weeks, and the hypofractionated RT (HRT) was 40.05 Gy/2.67 Gy in 3 weeks. Boost was applied as 10–16 Gy/2 Gy for CRT and 10 Gy/2.5 Gy for HRT. An equivalent conventional total dose of 2 Gy/fraction (EQD2) was taken into account for HRT.Results:HDM was 107±104 cGy, and LDM was 288±209 cGy for the entire group. HDM was significantly lower in patients with breast-conserving surgery (99±94 cGy) than that in those with mastectomy (128±124 cGy) (p<0.001). Field-in-field intensity-modulated RT technique significantly reduced the doses compared to volumetric applications (104±95 cGy vs 141±38 cGy; p = 0.002). HDM was significantly increased with lymphatic RT (132±58 cGy vs 112±115 cGy; p<0.001). The addition of internal mammary volumes significantly increased HDM (p<0.001). No significant effect of boost was observed (p = 0.96). For both CRT and HRT regimens, HDM values were significantly lower after the year 2014 (right side p<0.001, left side p = 0.01). In the left side CRT, HDM was 1.74 Gy before 2014 and 1.3 Gy after 2014 and 1.0 and 1.19 Gy, respectively, for the right side.Conclusion:All efforts to reduce the cardiac doses will likely reduce long-term side effects.
first_indexed 2024-04-10T12:53:17Z
format Article
id doaj.art-e5f72749b446486bb685b6cae51d48db
institution Directory Open Access Journal
issn 2587-0831
language English
last_indexed 2024-04-10T12:53:17Z
publishDate 2021-04-01
publisher Galenos Publishing House
record_format Article
series European Journal of Breast Health
spelling doaj.art-e5f72749b446486bb685b6cae51d48db2023-02-15T16:13:39ZengGalenos Publishing HouseEuropean Journal of Breast Health2587-08312021-04-0117214514910.4274/ejbh.galenos.2021.614813049054Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?Pelin Altınok0Latif Korkmaz1Ayse Altınok2Nuran Beşe3 Department of Radiation Oncology, University of Health Sciences Turkey, Ümraniye Training and Research Hospital, İstanbul, Turkey Research Institute of Senology, Acıbadem Maslak Hospital, İstanbul, Turkey Research Institute of Senology, Acıbadem Maslak Hospital, İstanbul, Turkey Research Institute of Senology, Acıbadem Maslak Hospital, İstanbul, Turkey Objective:In this study, we aimed to review the heart and left coronary artery doses over the years in patients who received breast cancer radiotherapy (RT).Materials and Methods:A total of 436 breast cancer patients of 2 RT centers treated between the years 2010 and 2018 were included. The mean heart doses (HeartDmean-HDM) and left coronary artery mean doses (LDM) were analyzed using nonparametric tests. The conventional RT (CRT) was 50 Gy/2 Gy in 5 weeks, and the hypofractionated RT (HRT) was 40.05 Gy/2.67 Gy in 3 weeks. Boost was applied as 10–16 Gy/2 Gy for CRT and 10 Gy/2.5 Gy for HRT. An equivalent conventional total dose of 2 Gy/fraction (EQD2) was taken into account for HRT.Results:HDM was 107±104 cGy, and LDM was 288±209 cGy for the entire group. HDM was significantly lower in patients with breast-conserving surgery (99±94 cGy) than that in those with mastectomy (128±124 cGy) (p<0.001). Field-in-field intensity-modulated RT technique significantly reduced the doses compared to volumetric applications (104±95 cGy vs 141±38 cGy; p = 0.002). HDM was significantly increased with lymphatic RT (132±58 cGy vs 112±115 cGy; p<0.001). The addition of internal mammary volumes significantly increased HDM (p<0.001). No significant effect of boost was observed (p = 0.96). For both CRT and HRT regimens, HDM values were significantly lower after the year 2014 (right side p<0.001, left side p = 0.01). In the left side CRT, HDM was 1.74 Gy before 2014 and 1.3 Gy after 2014 and 1.0 and 1.19 Gy, respectively, for the right side.Conclusion:All efforts to reduce the cardiac doses will likely reduce long-term side effects. http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/were-we-able-to-reduce-cardiac-doses-in-breast-can/47124 breast cancerradiotherapycardiac toxicity
spellingShingle Pelin Altınok
Latif Korkmaz
Ayse Altınok
Nuran Beşe
Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
European Journal of Breast Health
breast cancer
radiotherapy
cardiac toxicity
title Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
title_full Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
title_fullStr Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
title_full_unstemmed Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
title_short Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
title_sort were we able to reduce cardiac doses in breast cancer radiotherapy over time
topic breast cancer
radiotherapy
cardiac toxicity
url http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/were-we-able-to-reduce-cardiac-doses-in-breast-can/47124
work_keys_str_mv AT pelinaltınok wereweabletoreducecardiacdosesinbreastcancerradiotherapyovertime
AT latifkorkmaz wereweabletoreducecardiacdosesinbreastcancerradiotherapyovertime
AT aysealtınok wereweabletoreducecardiacdosesinbreastcancerradiotherapyovertime
AT nuranbese wereweabletoreducecardiacdosesinbreastcancerradiotherapyovertime